Risk assessment for hereditary breast cancer: BRCA1 and BRCA2

<p class="p1">The recent explosion of hereditary breast cancer genetic research has strengthened our understanding of genetic influences on health and disease. These scientific advances have significant implications for clinical oncology nurses and advanced practice nurses. In this p...

Full description

Bibliographic Details
Main Authors: Kendra-Ann I. Seenandan-Sookdeo, Jo-Ann V. Sawatzky
Format: Article
Language:English
Published: Pappin Communications 2010-08-01
Series:Canadian Oncology Nursing Journal
Online Access:https://canadianoncologynursingjournal.com/index.php/conj/article/view/176
_version_ 1797320030120050688
author Kendra-Ann I. Seenandan-Sookdeo
Jo-Ann V. Sawatzky
author_facet Kendra-Ann I. Seenandan-Sookdeo
Jo-Ann V. Sawatzky
author_sort Kendra-Ann I. Seenandan-Sookdeo
collection DOAJ
description <p class="p1">The recent explosion of hereditary breast cancer genetic research has strengthened our understanding of genetic influences on health and disease. These scientific advances have significant implications for clinical oncology nurses and advanced practice nurses. In this paper, the Human Response to Illness Model (Mitchell, Gallucci, &amp; Fought, 1991) is utilized to gain a comprehensive understanding of breast cancer related to the human response of genetic mutations. Accordingly, the research literature related to the physiological, pathophysiological, behavioural, and experiential perspectives of BRCA-related breast cancer will be highlighted. This research-based evidence will provide oncology nurses with the skills to establish a holistic plan of care for women with an actual or potential genetic risk for breast cancer.</p>
first_indexed 2024-03-08T04:15:38Z
format Article
id doaj.art-6f17872346174151b81437e05600641e
institution Directory Open Access Journal
issn 1181-912X
2368-8076
language English
last_indexed 2024-03-08T04:15:38Z
publishDate 2010-08-01
publisher Pappin Communications
record_format Article
series Canadian Oncology Nursing Journal
spelling doaj.art-6f17872346174151b81437e05600641e2024-02-08T16:28:54ZengPappin CommunicationsCanadian Oncology Nursing Journal1181-912X2368-80762010-08-01203107110174Risk assessment for hereditary breast cancer: BRCA1 and BRCA2Kendra-Ann I. Seenandan-SookdeoJo-Ann V. Sawatzky<p class="p1">The recent explosion of hereditary breast cancer genetic research has strengthened our understanding of genetic influences on health and disease. These scientific advances have significant implications for clinical oncology nurses and advanced practice nurses. In this paper, the Human Response to Illness Model (Mitchell, Gallucci, &amp; Fought, 1991) is utilized to gain a comprehensive understanding of breast cancer related to the human response of genetic mutations. Accordingly, the research literature related to the physiological, pathophysiological, behavioural, and experiential perspectives of BRCA-related breast cancer will be highlighted. This research-based evidence will provide oncology nurses with the skills to establish a holistic plan of care for women with an actual or potential genetic risk for breast cancer.</p>https://canadianoncologynursingjournal.com/index.php/conj/article/view/176
spellingShingle Kendra-Ann I. Seenandan-Sookdeo
Jo-Ann V. Sawatzky
Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
Canadian Oncology Nursing Journal
title Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
title_full Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
title_fullStr Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
title_full_unstemmed Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
title_short Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
title_sort risk assessment for hereditary breast cancer brca1 and brca2
url https://canadianoncologynursingjournal.com/index.php/conj/article/view/176
work_keys_str_mv AT kendraanniseenandansookdeo riskassessmentforhereditarybreastcancerbrca1andbrca2
AT joannvsawatzky riskassessmentforhereditarybreastcancerbrca1andbrca2